№ lp_1_2_02993
File format: docx
Character count: 58687
File size: 1893 KB
This document is a medical guideline that provides instructions for healthcare professionals on the use, management, and monitoring of anticoagulants for adult patients in Canberra Health Services.
Note:
Year
Subject:
Anticoagulation management in adults
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Target Audience:
Medical Officers
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
[year]
Region / City:
[region]
Topic:
Anticoagulation, Venous Thromboembolism, Kidney Disease
Document Type:
Clinical Practice Guideline
Institution / Organization:
UK Kidney Association
Author:
Kathrine Parker, Albert Power, Yvonne Bernes, Kate Bramham, Richard Buka, Satarupa Choudhuri, Mark Davies, Maria A Gauci, Lauren Hall, Alan Hancock, John Hartemink, Ed Jenkinson, Nicola Korn, Donna Lewis, Gregory Y.H. Lip, Katy Mills, Anneka Mitchell, Lara Roberts, Huw Rowswell, Hannah Stacey, Katherine Stirling, Jecko Thachil, Jung Tsang, Isaac Tseng
Target Audience:
Healthcare professionals in nephrology, haematology, and related fields
Period of Application:
Ongoing
Approval Date:
[month] [year]
Amendment Date:
[month] [year]
Year:
2013
Region / City:
Not specified
Subject:
Anticoagulation for HIT/HITTS patients undergoing cardiac surgery with CPB support
Type of Document:
Medical protocol
Institution:
Not specified
Author:
Not specified
Target Audience:
Healthcare professionals, specifically those involved in cardiac surgery and perfusion
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Revision:
Not specified
Clinical Assessment:
Contraindications: None
Related Documents:
Heparin Induced Thrombocytopenia Anticoagulation for Adult Cardiopulmonary Bypass
References:
Baker RA, Bronson SL, Dickinson TA, et al. (2013); Ibrahim W., Nakia H., Stephen M., et al. (2018); Tsu L.V., Dager W.E. (2011)
Year:
2026
Region / City:
Not specified
Theme:
Anticoagulation, Medical Competency, INR Testing
Document Type:
Competency Assessment
Organization / Institution:
Anticoagulation Team
Author:
Not specified
Target Audience:
Healthcare professionals involved in INR testing and anticoagulation services
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2020
Region / City:
United States
Topic:
Anticoagulation Management during COVID-19
Document Type:
Medical Protocol
Organization:
Anticoagulation Program
Author:
Not specified
Target Audience:
Healthcare Providers, Pharmacists, Anticoagulation Program Staff
Effective Period:
March 11, 2020 - Ongoing
Approval Date:
March 11, 2020
Modification Date:
Not specified
Year:
2016/17
Region / city:
Wandsworth
Topic:
Healthcare Services, Clinical IT, Medical Guidelines
Document Type:
Guidelines
Target Audience:
Healthcare professionals, medical staff
Effective Period:
2016-2017
Approval Date:
Not specified
Modification Date:
Not specified
Year:
N/A
Region / City:
N/A
Subject:
Therapeutic Hypothermia, Neonatal Care
Document Type:
Clinical Guideline
Organization:
N/A
Author:
N/A
Target Audience:
Healthcare Providers
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Year
Topic:
Behavioral Health Services
Document Type:
Assessment Tool
Target Audience:
Service providers, healthcare professionals
Year:
2023
Region/City:
Illinois
Topic:
Youth support services, Therapeutic support services, Prior authorization process
Document Type:
Form
Organization:
Illinois Department of Healthcare and Family Services (HFS)
Author:
Unknown
Target Audience:
Providers of therapeutic and individual support services
Period of Action:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2021
Region / City:
Australia
Topic:
Vaporiser Nicotine Product Standards
Document Type:
Legislative Instrument
Organization / Institution:
Department of Health
Author:
[Name of delegate]
Target Audience:
Manufacturers, Health Authorities, Regulatory Bodies
Period of Validity:
From 1 October 2021
Approval Date:
1 October 2021
Amendment Date:
Not specified
Year:
2021
Region / City:
Philadelphia
Theme:
Health Communication, Education
Document Type:
Course Syllabus
Institution:
Community College of Philadelphia
Author:
Jocelyn Lewis
Target Audience:
Students in health-related fields
Effective Period:
Fall 2021
Approval Date:
February 10, 2021
Date of Revisions:
February 10, 2021
Year:
2026
Region / City:
Canberra, Australia
Topic:
Haemodialysis, Plasma Exchange, Medical Procedures
Document Type:
Clinical Procedure
Organization / Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Renal Nurses, Medical Staff
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Last Revision:
Not specified
Year:
[effective date]
Region / City:
[Facility Location]
Topic:
Intravenous to Oral Antibiotic Conversion
Document Type:
Policy
Organ / Institution:
[Facility Name]
Author:
[Approving individual or committee]
Target Audience:
Clinical staff, healthcare providers
Period of Effectiveness:
[Effective date]
Approval Date:
[Approval Date]
Date of Changes:
[Date of Changes]
Year:
Not specified
Region / City:
Not specified
Theme:
Therapeutic hypothermia for newborns, clinical protocols
Document Type:
Clinical guideline
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Medical professionals involved in neonatal care
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
November 2025
Region / City:
Trust-wide
Topic:
Therapeutic Engagement, Observation, Mental Health Care
Document Type:
Policy
Organization:
Borough Lead Nurses, Quality Committee
Author:
Director of Nursing
Target Audience:
Healthcare staff, Mental Health and LD services
Period of Validity:
November 2025 – November 2028
Approval Date:
November 2025
Date of Changes:
August 2024, November 2025
Year:
2026
Country:
Australia
Type of document:
Application form
Issuing authority:
Therapeutic Goods Administration (TGA)
Intended audience:
Medical practitioners
Purpose:
Application to become an authorised prescriber of unapproved medicines or medical devices
Regulatory reference:
Therapeutic Goods Regulations 1990, Regulation 12B(1B)
Required attachments:
Ethics committee or specialist college approval/declaration (if applicable)
Information collected:
Personal details of medical practitioner, patient consent, product information, prescribing details
Submission method:
Email or fax to TGA
Year:
2022
Region / City:
Norfolk, Norwich
Topic:
Nuclear Medicine
Document Type:
Procedural Document
Organization / Institution:
Norfolk and Norwich University Hospitals NHS Foundation Trust
Author:
Matthew Gray
Target Audience:
Medical staff working in nuclear medicine and related departments
Effective Date:
14/12/2022
Review Date:
12/2024
Date of Approval:
12/2022
Date of Amendments:
10/08/2022
Research Theme: Cancer Biology - Investigating R-Loop Biology for Therapeutic Applications in Cancer
Year:
Not specified
Region / City:
Not specified
Subject:
Cancer Biology, R-Loop Biology
Document Type:
Research Project Proposal
Institution:
Not specified
Author:
Li Hoi Yeung
Target Audience:
PhD candidates, researchers in cancer biology
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2020
Region / city:
Global
Topic:
COVID-19, Clinical Trials, Remote Monitoring, Data Verification
Document Type:
Guide/Playbook
Organization:
European Medicines Agency (EMA)
Author:
Not specified
Target Audience:
Clinical Trial Monitors, Healthcare Professionals, Regulatory Agencies
Period of Action:
Ongoing during COVID-19 pandemic
Approval Date:
July 2020
Date of Changes:
Not specified